Home β€Ί Healthcare β€Ί Medical Devices β€Ί Pen Needle Market

Pen Needle Market Size, Share, Opportunities, And Trends By Type (Standard Pen Needles, Safety Pen Needles), By Length (4mm and 5mm, 6mm and 8mm, 10mm and 12mm), By Therapy (Insulin, Glucagon-like-Peptide-1, Growth Hormone), By Distribution Channel (Online, Offline), And By Geography - Forecasts From 2025 To 2030

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Table of Contents

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.1.1. Growing Demand for Packaging

4.1.2. Increasing Focus on Sustainability

4.2. Market Restraints

4.2.1. Environmental Concerns

4.2.2. High Production Cost

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. The Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

 

5. PEN NEEDLE MARKET BY TYPE

5.1. Introduction

5.2. Standard Pen Needles

5.3. Safety Pen Needles

6. PEN NEEDLE MARKET BY LENGTH

6.1. Introduction

6.2. 4mm and 5mm

6.3. 6mm and 8mm

6.4. 10mm and 12mm

7. PEN NEEDLE MARKET BY THERAPY

7.1. Introduction

7.2. Insulin 

7.3. Glucagon-like-Peptide-1

7.4. Growth Hormone

8. PEN NEEDLE MARKET BY DISTRIBUTION CHANNEL

8.1. Introduction

8.2. Online

8.3. Offline

9. PEN NEEDLE MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America 

9.2.1. United States 

9.2.2. Canada 

9.2.3. Mexico 

9.3. South America 

9.3.1. Brazil 

9.3.2. Argentina 

9.3.3. Others

9.4. Europe 

9.4.1. UK 

9.4.2. Germany 

9.4.3. France 

9.4.4. Spain 

9.4.5. Italy 

9.4.6. Others

9.5. Middle East and Africa 

9.5.1. UAE 

9.5.2. Saudi Arabia 

9.5.3. Others

9.6. Asia Pacific 

9.6.1. Japan 

9.6.2. China 

9.6.3. India 

9.6.4. South Korea 

9.6.5. Indonesia 

9.6.6. Thailand 

9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Emerging Players and Market Lucrativeness

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

11.1. Becton, Dickinson and Company 

11.2. Glucorx 

11.3. Braun Melsungen 

11.4. Ypsomed 

11.5. Novo Nordisk 

11.6. HTL-Strefa 

11.7. Ultimed, Inc. 

11.8. Allison Medical, Inc.  

11.9. Terumo Corporation 

11.10. Owen Mumford, Ltd.  

REPORT DETAILS

Report ID:KSI061613464
Published:Jan 2025
Pages:145
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us